News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Get all the news you need in your inbox each morning. As of July 1, CVS dropped Zepbound from preferred coverage for those covered by its pharmacy benefit manager, Caremark. Novo Nordisk A/S's Wegovy, ...
The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...
The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics that are reshaping how weight-loss treatments are covered under insurance ...
Explore more
CVS Caremark is the largest PBM in the U.S., accounting for 33% of all prescriptions filled nationally. CVS denies the allegations. “We believe the allegations are without merit and intend to ...
CVS Health’s pharmacy benefit manager (PBM), CVS Caremark, joined forces with GoodRx to launch a prescription drug cost-saving program Wednesday. The Caremark Cost Saver gives CVS Caremark members the ...
CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs.
CVS Caremark decided to return Eliquis to its formulary after negotiating a lower net cost, a spokesperson wrote in an email Tuesday. "Anticoagulant therapies are among the non-specialty products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results